CYVURE Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for CYVURE with the United States Patent and Trademark Office. The USPTO has given the CYVURE trademark a serial number of 79263026. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2020. This trademark is owned by Glaxo Group Limited. The CYVURE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
cyvure

General Information


Serial Number79263026
Word MarkCYVURE
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, February 18, 2020
Registration Number5986945
Registration DateTuesday, February 18, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMiddlesex TW8 9GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMiddlesex TW8 9GS
GB

Trademark Events


Event DateEvent Description
Sunday, July 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 4, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 4, 2020FINAL DISPOSITION PROCESSED
Monday, May 18, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 18, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 2, 2019REFUSAL PROCESSED BY IB
Thursday, October 31, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 31, 2019ASSIGNED TO LIE
Saturday, October 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 11, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 11, 2019REFUSAL PROCESSED BY MPU
Tuesday, October 1, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 30, 2019NON-FINAL ACTION WRITTEN
Monday, September 30, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, September 25, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 24, 2019NON-FINAL ACTION WRITTEN
Saturday, August 24, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, August 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 5, 2019NON-FINAL ACTION WRITTEN
Thursday, August 1, 2019ASSIGNED TO EXAMINER
Tuesday, July 23, 2019APPLICATION FILING RECEIPT MAILED
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB